Many people have diabetes but don’t know it. During the month of March the American Red Cross will be helping to bridge access to health care by providing a free A1C (diabetes screening) test for ...

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...

The ctDNA test showed 79.2% sensitivity and 91.5% specificity for CRC detection in a diverse cohort. The study met primary end points but had limited sensitivity for advanced precancerous lesions.

The new test is less invasive and time-consuming than the gold standard test. But it has some shortfalls—and experts say it’s important to consider all your options. This is a fluorescent micrograph ...

Delfi Diagnostics is launching its first liquid biopsy test, fulfilling the company’s own, years-long prophecy to offer a new blood-based tool for the screening of lung cancer. Its Firstlook Lung test ...

To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but also ...